Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 788-795

  Freemerman, Alex J ^a   Turner, Amy J ^a   Birrer, Michael J ^b   Szabo, Eva ^b   Valerie, Kristoffer ^a   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN C; CHELERYTHRINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; ONCOPROTEIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; DNA DEGRADATION; ETIOLOGY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; ONCOGENE C JUN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RNA DEGRADATION;

ALKALOIDS; APOPTOSIS; BENZOPHENANTHRIDINES; DNA DAMAGE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, JUN; HL-60 CELLS; HUMANS; NAPHTHALENES; PHENANTHRIDINES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; UP-REGULATION;

EID: 0029978386     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Angel, P., and M. Karin. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157 (1991).
2. Nakabeppu, Y., K. Ryder, and D. Nathans. DNA binding activities of three murine jun proteins: stimulation by fos. Cell 55:907-915 (1988).
3. Lau, L F., and D. Nathans. Expression of a set of growth-related immediate early genes in BALB/cT3T cells: coordinate regulation with c-fos or c-myc. Proc Natl. Acad. Sci. USA 84:1182-1187 (1987).
4. Ryder, K., and D. Nathans. Induction of protooncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA 85:8464-8467 (1988).
5. Angel, P., K. Hattori, T. Smeal, and M. Karin. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885 (1988).
6. Lee, W., P. Mitchell, and R. Tjian. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752 (1987).
7. Bohmann, D., T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science (Washington D. C.) 238:1386-1392 (1987).
8. Angel, P., E. A. Allegretto, S. T. Okino, K. Hattori, W. J. Boyle, T. Hunter, and M. Karin. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature (Lond.) 332:166-171 (1988).
9. Quantin, B., and R. Breathnach. Epidermal growth factor stimulates transcription of c-jun proto-oncogene in rat fibroblasts. Nature (Lond.) 334: 538-539 (1988).
10. Brenner, D. A., M. O'Hara, P. Angel, M. Chojikier, and M. Karin Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature (Lond.) 337:661-663 (1989).
11. Wu, B., E. J. B. Fodor, R. H. Edwards, and W. J. Rutter. Nerve growth factor induces the proto-oncogene c-jun in PC12 cells. J. Biol. Chem. 264:9000-9003 (1989).
12. Sherman, M., R. Stone, R. Datta, S. Bernstein, and D. Kufe. Transcriptional and posttranscriptional regulation of c-jun expression during induction of monocytic differentiation. J. Biol. Chem. 265:3320-3323 (1990).
13. Rubin, E., S. Kharbanda, H. Gunji, and D. Kufe. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol. Pharmacol. 39:697-701 (1991).
14. Kim, R., and W. T. Beck. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Res. 54:4958-4966 (1994).
15. Gunji, H., S. Kharbanda, and D. Kufe. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res. 51:741-743 (1991).
16. Kharbanda, S., E. Rubin, H. Gunji, H. Hinz, B. Giovanella, P. Pantazis, and D. Kufe. Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells. Cancer Res. 51: 6636-6642 (1991).
17. Rubin, E., S. Kharbanda, H. Gunji, R. Weichselbaum, and D. Kufe, cis-Diamminedichloroplatinum(II) induces c-jun expression inhuman myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res. 52:878-882 (1992).
18. Colotta, F., N. Polentarutti, M. Sironi, and A. Mantovani. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267:18278-18283 (1992).
19. Estus, S., W. J. Zaks, R. S. Freeman, M. Gruda, R. Bravo, and E. M. Johnson. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell. Biol. 127:1717-1728 (1994).
20. Ham, J., C. Babij, J Whitfield, C. M. Pfarr, D. Lallemand, M. Yaniv, and L L. Rubin. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939 (1995).
21. Bullock, G., S. Ray, J. Reed, T. Miyashita, A. M. Ibrado, Y. Huang, and K. Bhalla. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Clin. Cancer Res. 1:559-564(1995).
22. Boyle, W. J., T. Smeal, L. H. K. Defize, P. Angel, J. R. Woodgett, M. Karin, and T. Hunter. Activation of protein kinase C decreases phosphorylation of c-jun at sites that negatively regulate its DNA-binding activity. Cell 64: 573-584 (1991).
23. Hallahan, D. E., V. P. Sukhatme, M. L. Sherman, S. Virudachalam, D. Kufe, and R. R. Weichselbaum. Protein kinase C mediates X-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc. Natl. Acad. Sci. USA 88:2156-2160 (1991).
24. Kharbanda, S., R. Datta, and D. Kufe. Regulation of c-jun gene expression in HL-60 leukemia cells by 1-β-D-arabinofuranosylcytosine: potential involvement of a protein kinase C dependent mechanism. Biochemistry 30:7947-7952 (1991)
25. Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707-1714 (1994).
26. Gorczyca, W., J. Gong, B. Ardelt, F. Traganos, and Z. Darzynckiewicz. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53:3186-3192 (1993).
27. Bertrand, R., E. Solary, P. O'Connor, K. W. Kohn, and Y. Pommier. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211:314-321 (1994).
28. Grant, S., A. J. Turner, T. M. Bartimole, P. A. Nelms, V. C. Joe, and W. D. Jarvis. Modulation of 1-[β-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncol. Res. 6:287-99 (1994).
29. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553 (1989).
30. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P. Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:993-999 (1990).
31. Gallegher, R., S. Collins, J. Trujillo, K. McCredie, M. Ahearn, S. Tsai, R. Metzgar, G. Aulakh, R. Ting, F. Ruscetti, and R. Gallo. Characterization of the continuous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713-733 (1979).
32. Sundstrom, C., and K. Nilsson. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17:565-577 (1976).
33. Szabo, E., L. H. Preis, and M. J. Birrer Constitutive cJun expression induces partial macrophage differentiation in U937 cells. Cell Growth Differ. 5:439-446 (1994).
34. Brown, P. H., P. Alani, L. H. Preis, E. Szabo, and M. J. Birrer. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:877-886 (1993).
35. Bruns, R. F., F. D. Miller, R. L. Merriman, J. J. Howbert, W. F. Heath, E. Kobayashi, I. Takahashi, T. Tamaoki, and H. Nakano. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem. Biophys. Res. Commun. 716:288-293 (1991).
36. 2+ chelator BAPTA/AM Oncol. Res. 7:381-392 (1995).
37. Brown, P. H., T. K. Chen, and M. J. Birrer. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-799 (1994).
38. Ritke, M. K-, V. V. Bergoltz, W. P. Allan, and J. C. Yalowich. Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochem Pharmacol. 48:525-533 (1994).
39. Kolla, S. S., and G. P. Studzinski. Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL-60 cells resistant to 1-β-D arabinofuranosylcytosine. Cancer Res. 54:1418-1421 (1994).
40. Brach, M. A., F. Herrmann, and D. W. Kufe. Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells. Blood 79:728-734 (1992).
41. Hass, R., H.-J. Pfannkuche, S. Kharbanda, H. Gunji, G. Meyer, A Hartmann, H. Hidaka, K. Resch, D. Kufe, and M. Goppelt-Strube. Protein kinase C activation and protooncogene expression in differentiation/ retrodifferentiation of human U-937 leukemia cells. Cell Growth Differ. 2:541-548 (1991).
42. Edashige, K., E. F. Sato, K. Akimaru, M. Kasai, and K. Utsumi. Differentiation of HL-60 cells by phorbol ester is correlated with up-regulation of protein kinase C-α. Arch. Biochem Biophys. 299:200-205 (1992).
43. Kraft, A. S., F. William, G. R. Pettit, and M. B. Lilly. Varied differentiation responses of human leukemias to bryostatin 1. Cancer Res. 49:1287-1293 (1989).
44. Grant, S., W. D. Jarvis, P. S. Swerdlow, A. J. Turner, R. S. Traylor, H. J. Wallace, P.-S. Lin, G. R. Pettit, and D. A. Gewirtz. Potentiation of the activity of 1-β-D- arabinofuranosylcytosine by the macrocyclic lactone PKC activator bryostatin is associated with enhanced fragmentation of mature DNA. Cancer Res, 52:6270-6278 (1992).
45. Stone, R., E. Sariban, G. R. Pettit, and D. W. Kufe. Bryostatin activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72:208-213 (1988).
46. Petrak, D., S. A. Memon, M. J. Birrer, J. D. Ashwell, and C. M. Zacharchuk. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol. 153:2046-2051 (1994).
47. Domann, F. E., J. P. Levy, M. J. Birrer, and G. T. Bowden. Stable expression of a c-Jun deletion mutant and two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 5:9-16 (1994).
48. Westwick, J. K., A. E. Bielawska, G. Dbiabo, Y. A. Hannun, and D. A. Brenner. Ceramide activates the stress-activated protein kinases. J. Cell. Biol. 270:22689-22692 (1995).
49. Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington D. C.) 257:212-214 (1992).